Diurnal, Seasonal, and Monthly Variations in Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators

被引:3
|
作者
Maan, Abhishek [1 ]
Sherfesee, Lou [2 ]
Lexcen, Daniel [2 ]
Heist, E. Kevin [1 ]
Cheng, Alan [2 ]
机构
[1] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA USA
[2] Medtron, 8200 Coral Sea St,MVS 2, Mounds View, MN 55112 USA
关键词
defibrillators; diurnal variation; ventricular arrhythmias; SUDDEN CARDIAC DEATH; CIRCADIAN VARIATION; MYOCARDIAL-INFARCTION; TACHYARRHYTHMIAS; TACHYCARDIA; MORTALITY; PLATELET; CORONARY; INTERVAL; THERAPY;
D O I
10.1016/j.jacep.2019.05.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this study was to assess the variations in ventricular arrhythmia (VA) occurrence according to seasons, months of the year, days of the week, and the time of day in a large implantable cardioverter-defibrillator patient population. BACKGROUND Limited data exist on how VA occurrence varies as a function of time. METHODS Data from 6 prospective studies were pooled to assess VA frequency over time. All adjudicated episodes of VAs <= 500 ms were included. VA distribution as a function of hour, day, month, and season were assessed through the construction of 4 negative binomial models. The models included a random patient effect and offset for days spent in each time period. RESULTS Among 3,969 patients, 7,126.8 cumulative device-years with an average follow-up duration of 1.8 +/- 1.4 years/patient were analyzed. VA occurrence was higher in the spring than the summer (0.86% vs. 0.70%; p = 0.009) but not significantly different from the fall (0.74%; p = 0.069) or winter (0.84%; p = 0.732). The estimated probability of occurrence of at least 1 VA episode in each 1-h block during the hours of 8 AM to 10 PM over 365 days (0.10% to 0.12%) was higher (estimated 35% to 63% higher) than the referent period of midnight to 1 AM (0.07%). No significant variations in VA occurrence were observed according to weekday and individual months of the year. CONCLUSIONS Significantly higher VA occurrence in the spring and during the hours of 8 AM to 10 PM were observed. Additional studies are needed to further understand the reasons for these observations, which may involve variations in temperature or differences in catecholamine triggers. (C) 2019 by the American College of Cardiology Foundation.
引用
收藏
页码:979 / 986
页数:8
相关论文
共 50 条
  • [1] Ventricular arrhythmias and cardiac arrest in atrial fibrillation patients with pacemakers and implantable cardioverter-defibrillators
    Fawzy, Ameenathul M.
    Bisson, Arnaud
    Bentounes, Sid A.
    Bodin, Alexandre
    Herbert, Julien
    Lip, Gregory Y. H.
    Fauchier, Laurent
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 115 : 70 - 78
  • [2] Weather and triggering of ventricular arrhythmias in patients with implantable cardioverter-defibrillators
    Nguyen, Jennifer L.
    Laden, Francine
    Link, Mark S.
    Schwartz, Joel
    Luttmann-Gibson, Heike
    Dockery, Douglas W.
    JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY, 2015, 25 (02) : 175 - 181
  • [3] The Effect of Spironolactone on Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators
    Zarraga, Ignatius Gerardo E.
    Dougherty, Cynthia M.
    MacMurdy, Karen S.
    Raitt, Merritt H.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (04): : 739 - 747
  • [4] Mortality Risk Increases With Clustered Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators
    Elsokkari, Ihab
    Parkash, Ratika
    Tang, Anthony
    Wells, George
    Doucette, Steve
    Yetisir, Elizabeth
    Gardner, Martin
    Healey, Jeffrey S.
    Thibault, Bernard
    Sterns, Laurence
    Birnie, David
    Nery, Pablo
    Sivakumaran, Soori
    Essebag, Vidal
    Dorian, Paul
    Sapp, John
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2020, 6 (03) : 327 - 337
  • [5] Destabilizing effects of mental stress on ventricular arrhythmias in patients with implantable cardioverter-defibrillators
    Lampert, R
    Jain, D
    Burg, MM
    Batsford, WP
    McPherson, CA
    CIRCULATION, 2000, 101 (02) : 158 - 164
  • [6] The Association between Statin Dosage and Malignant Ventricular Arrhythmias in Patients with Primary Prevention Implantable Cardioverter-defibrillators for Ischemic Cardiomyopathy
    Karaaslan, Ozge Cakmak
    Aksoy, Atik
    Ozilhan, Murat Oguz
    Guray, Umit
    Selcuk, Mehmet Timur
    Selcuk, Hatice
    Maden, Orhan
    RESEARCH IN CARDIOVASCULAR MEDICINE, 2023, 12 (03) : 89 - 92
  • [7] Implantable Cardioverter-Defibrillators in Patients With COPD
    Naksuk, Niyada
    Kunisaki, Ken M.
    Benditt, David G.
    Tholakanahalli, Venkatakrishna
    Adabag, Selcuk
    CHEST, 2013, 144 (03) : 778 - 783
  • [8] Fragmented QRS and arrhythmic events in patients with implantable cardioverter-defibrillators
    Kucharz, Anna
    Kulakowski, Piotr
    KARDIOLOGIA POLSKA, 2020, 78 (11) : 1107 - 1114
  • [9] Effect of diurnal variations in the QRS complex and T waves on the eligibility for subcutaneous implantable cardioverter-defibrillators
    Miwa, Naoyuki
    Nagata, Yasutoshi
    Yamaguchi, Tetsuo
    Nagase, Masashi
    Sasaki, Takeshi
    Nozato, Toshihiro
    Ashikaga, Takashi
    Goya, Masahiko
    Hirao, Kenzo
    HEART RHYTHM, 2019, 16 (06) : 913 - 920
  • [10] The Role of Implantable Cardioverter-Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices
    Enriquez, Alan D.
    Calenda, Brandon
    Miller, Marc A.
    Anyanwu, Anelechi C.
    Pinney, Sean P.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (04): : 668 - 674